Titlebook: Cardiovascular Regenerative Medicine; Tissue Engineering a Vahid Serpooshan,Sean M. Wu Book 2019 Springer Nature Switzerland AG 2019 3D bio

不出名

Regenerative Medicine for the Treatment of Congenital Heart Disease,ticular population. Physicians now have a broad range of therapeutic option: medical therapy, interventional procedures, or surgery. Nevertheless, shortcomings remain. The ongoing developments in regenerative medicine pave the way toward a new area in the management of CHD, especially regarding surg

真

HACK

組成

Obstruction

HAUNT

https://doi.org/10.1007/978-94-015-9578-0neering strategies represent an important class of therapeutics which aim to address the insufficiencies of current management of heart failure and related sequelae. Here, we review the various tissue engineering strategies which address the limitations of current therapies and represent promising adjunct treatments to the current gold standard.

玉米

ordain

3D Bioprinting of Cardiovascular Tissue Constructs: Cardiac Bioinks,ivo applications. Hydrogel-based bioinks must fulfill several key biophysical and biochemical requirements, before, during, and post-printing processes. This chapter explores in depth the parameters that are necessary for a successful bioink solution that can support cardiac tissue structure and function.

conscribe

Tissue-Engineered Stem Cell Models of Cardiovascular Diseases,erated to create culture systems that better recapitulate the complex 3D microenvironments found in living tissue. By using these engineered models, more relevant data may be produced to unravel the molecular underpinnings of disease states and potentially translate into new therapeutic strategies.

尖叫